aneurysm. [9] [10] [11] Furthermore, Smad4 haploinsufficiency exacerbates aortic disease in a Marfan syndrome mouse model. 12 However, the exact role of vascular smooth muscle Smad4 in the pathogenesis of aortic aneurysms is largely unknown.
When compared with other hereditary syndromic aneurysmal conditions, such as Marfan syndrome, LDS often presents a more aggressive vascular pathology with a high risk for aortic dissection and rupture throughout the arterial tree. 13, 14 In LDS mouse models, the severity of the aneurysm pathology correlates to the presence of infiltrating leukocytes in the dissected aortas. 15 Nevertheless, the pathological effects of such infiltration, the inflammatory cell types, and the pathways involved are not clearly defined. Whether TGF-β signaling disruption in vascular smooth muscle cells (SMCs) could directly trigger aortic wall inflammation remains poorly investigated.
In the present study, by using the conditional knockout strategy, we revealed a pivotal role of smooth muscle Smad4 signaling in maintaining aortic wall homeostasis. Smad4-dependent TGF-β signaling in SMCs restrained the excessive production of the proteases essential for elastin degradation and protected against the development of aortic aneurysms. In addition, we demonstrated that Smad4 deficiency in SMCs directly triggered an inflammation-mediated progression of aortic aneurysms, which suggests important implications for novel therapeutic strategies on LDS.
Methods
The detailed Methods section is available in the Online Data Supplement.
Results

Deletion of Smad4 in SMCs Results in Aortic Aneurysm and Dissection
To study the role of vascular SMC intrinsic Smad4 signaling in aortic wall homeostasis, we deleted Smad4 gene specifically in SMCs by using an α-SMA-Cre transgenic mouse line. 16 The Cre-mediated recombination occurred predominantly in postnatal aortic SMCs but was scarce in embryonic aortic SMCs ( Figure 1A ; Online Figure  I ). The α-SMA-Cre;Smad4 fl/+ was chosen as the control because there was no apparent difference in the aortic structures between α-SMA-Cre;Smad4 fl/+ and wild-type mice (Online Figure II) . Next, we used Western blot to confirm the marked decrease of Smad4 in the aortic media of α-SMA-Cre;Smad4 fl/fl mice ( Figure 1B ). Smad4 disruption in SMCs led to the development of both thoracic and abdominal aortic aneurysms in 100% of the mice, with 100% mortality from aneurysm rupture between 3 and 10 weeks old ( Figure 1C ).
Echocardiography further demonstrated the progressive dilatation in both thoracic and abdominal aortas in the mutants ( Figure 1D ; Online Figure III ).
Histological analysis of the aortic wall showed comparable cellular constitution but disarrayed elastic fibers in the mutant mice at 3 weeks. As the aneurysms developed, the Smad4 mutants displayed typical pathological performances of the inherited aortic aneurysm, including aortic wall thickening and medial degeneration characterized by destructive extracellular matrix remodeling with elastin fragmentation ( Figure 1E and 1F). Notably, aortic dissection rapidly developed, involving both thoracic and abdominal aortas, evidenced by intense cell infiltration and erythrocyte extravasation mainly into the media ( Figure 1G ). Although the α-SMA-Cre-mediated ablation also occurred in a subset of adult myocardium and SMCs along the digestive tract, no histological abnormalities were detected in these tissues (Online Figure IV) .
Defective Canonical but Increased Noncanonical TGF-β Signaling in the Aortas of the Smad4 Mutants
To determine the signaling changes by Smad4 deletion in SMCs, we isolated primary mouse aortic SMCs and cultured them in vitro. The TGF-β1-induced upregulation of plasminogen activator inhibitor type 1 was completely blocked in the SMCs derived from the Smad4 mutants, verifying the diminished TGF-β responsiveness in the absence of Smad4 (Figure 2A and 2B). We analyzed the aortic tissues at about 3 weeks with few morphological abnormalities. Real-time polymerase chain reaction was used to check the transcription of the downstream targets and the ligands of the TGF-β pathway in the aortic tissues with adventitia removed. We found an obvious decrease in the expression of plasminogen activator inhibitor type 1 and inhibitor of DNA binding 1, direct targets of the canonical TGF-β and bone morphogenetic protein pathways, respectively, which confirmed that the TGF-β superfamily signaling was compromised by Smad4 disruption ( Figure 2C ; Online Figure V) .
We also observed an obvious increase of connective tissue growth factor (CTGF) expression in the Smad4 mutant tissue ( Figure 2C ; Online Figure VI ). In addition, TGF-β3, but not TGF-β1 or TGF-β2, was increased by Smad4 disruption ( Figure 2C ; Online Figure VI) . Next, we checked the intracellular mediators of the canonical and noncanonical TGF-β signaling. We found enhanced activation of Smad2, Smad3, and JNK, but not extracellular signal-regulated kinase or thymoma viral proto-oncogene 1, in the aortic wall of Smad4 mutants (Figure 2D and 2E; Online Figures VI and VII).
We further revealed a dispensable role of Smad2 activation in the signaling changes resulting from Smad4 deletion (Online Figure VIII) , which is in line with the notion that Smad4 lies downstream of Smad2 to transduce TGF-β signaling. 3, 4 CTGF is a well-known TGF-β-responsive factor. Of note, we demonstrated that the JNK inhibitor blocked both the TGF-β1-induced CTGF expression in wild-type SMCs and the upregulation of CTGF in the Smad4-deficient SMCs ( 
Smad4 Deficiency in SMCs Results in an Upregulation of the Proteases Essential for Elastin Degradation
Next, we assessed the cellular behaviors underlying the pathogenesis of aortic aneurysms resulting from Smad4 disruption in SMCs. The 5-bromo-2′-deoxyuridine incorporation assay demonstrated a slightly increased cell proliferation in the mutant aortic wall, especially in the outer media ( Figure 3A) , which is reasonable because Smad4 is a well-known growth inhibitor for multiple cell types. 17 However, in vitro studies using both knockdown and overexpression strategies showed that Smad4 did not significantly affect SMC proliferation, survival, or apoptosis (Online Figure X) . Supportively, previous data also show that Smad4 does not affect the proliferation of SMCs in vitro. 18, 19 Smad4 overexpression in vitro induced the expression of some differentiation markers, including α-SMA and myocardin, and also several dedifferentiation markers, including collagen III, fibronectin, and vimentin (Online Figure XI) , which correlated with the expected role of TGF-β on the induction of contractile protein and extracellular matrix expression. 20 Nevertheless, we detected normal expression of differentiation and dedifferentiation markers excepted for an elevated expression of osteopontin in the Smad4-deficient SMCs both in vivo and in vitro (Figure 3B and 3C; Online Figure XI) . We also did not detect any effect of Smad4 on the morphology of the SMCs (Online Figure XI) . These findings indicated the dispensable role of endogenous Smad4 in SMC phenotypic switching. No apparent difference in the expression of collagens was detected in the aortas of 3-week-old control and mutant mice (Online Figure XII) . In addition, oxidative stress in the aortic wall was comparable between the control and Smad4 mutants (Online Figure XIII and Table I ).
Of note, transmission electron microscopy detected a robust disruption of elastic fibers in the Smad4-deficient aortic wall, particularly in the outer media, in mice only 2 weeks old ( Figure 3D ). Therefore, we focused on a series of genes involved in the biological processes of elastic fibers. For those genes essential for elastin synthesis and assembly, we detected a decrease in the expression of elastin, lysyl oxidase, fibulin-4, and fibulin-5 in the Smad4-deficient aortic media ( Figure 3E ). We also screened for the genes responsible for extracellular matrix degradation and detected a marked increase in the expression of cathepsin S (CTSS) and matrix metallopeptidase (MMP)-12, as well as the activation of MMP12, in the aortic tissues of Smad4 mutants ( Figure 3F ; Online Figure VI) . In contrast, the expression and the activity of MMP2 and MMP9 were unchanged ( Figure 3F ; Online Figure XIV ), in line with the in vitro findings that Smad4 did not regulate the expression of MMP2 and MMP9 in SMCs (Online Figure XI) . We further verified the upregulation of the proteases CTSS and MMP12 in the aortic media of 3-week-old Smad4 mutants ( Figure 3G ). Consistently, the in situ zymography showed apparently higher elastinolytic activity in the mutants ( Figure  3H ). The elevation of the 2 proteases was also detected in the primary isolated SMCs from the mutants, suggesting that the Smad4-deficient SMCs were the major derivation of the excessive production ( Figure 3I ). Importantly, we demonstrated a negative effect of TGF-β1 on the expression of MMP12 in aortic SMCs, which is largely abrogated in the absence of Smad4 ( Figure 3J ). Interestingly, JNK also partially participated in the upregulation of MMP12 in the Smad4-deficient SMCs ( Figure 3J ). Nevertheless, neither TGF-β1 nor JNK showed regulatory effects on CTSS expression (Online Figure  XV) , suggesting that there might be an indirect regulation. In summary, intrinsic Smad4 signaling in SMCs maintained aortic wall homeostasis presumably via regulating the expression of the genes involved in elastin biosynthesis and degradation.
Deletion of Tgfbr2 in SMCs Leads to Aortic Aneurysms Accompanied by the Increased Expression of CTSS and MMP12
Using the same α-SMA-Cre transgenic mice, we further generated a Tgfbr2 conditional knockout mouse model in which canonical TGF-β signaling was blocked without the simultaneously activation of noncanonical TGF-β signaling in SMCs. Tgfbr2 disruption in SMCs resulted in the occurrence of both thoracic and abdominal aortic aneurysms in 100% of the mice ( Figure 4A-4C) . Histologically, Verhoeff-Van Gieson staining validated the disruption of elastic fibers in the 4-weekold Tgfbr2 mutants ( Figure 4D ). We observed a decrease in the TGF-β targets plasminogen activator inhibitor type 1 and CTGF expression and an increase in TGF-β3 expression, which confirmed that the TGF-β signaling was blocked in the absence of Tgfbr2 ( Figure 4E ). Of note, no differences were detected in the activation of intracellular mediators, including Smad2, JNK, extracellular signal-regulated kinase, and thymoma viral proto-oncogene 1, in the aortic media between the control and the Tgfbr2 mutant mice ( Figure 4F ). Next, we verified the downregulation of CTGF and the diminished responsiveness to the TGF-β-induced Smad2 activation and CTGF upregulation in the Tgfbr2-deficient primary aortic SMCs ( Figure 4G ; Online Figure XVI ). Similar to the Smad4 mutants, the Tgfbr2 mutants showed normal SMC differentiation (Online Figure XVI) . We also demonstrated a decrease of elastin, lysyl oxidase, and fibulin-5 expression in the Tgfbr2-deficient aortic media ( Figure 4H ), which correlated with the findings from the Smad4 mutants. Importantly, we detected an evidently increased expression of CTSS and MMP12 in the aortic media of the Tgfbr2 mutants at both transcript and protein levels ( Figure 4I-4K ), validating the negative regulating role of TGF-β1 on MMP12 expression in aortic SMCs. These results confirmed that a disrupted canonical TGF-β signaling pathway in SMCs caused aortic aneurysms. 
Macrophage Infiltration Contributes to the Progression of Aortic Aneurysms Resulting From Smad4 Deficiency in SMCs
As all of the Smad4 mutant mice demonstrated a lethal aortic dissection, we investigated whether leukocyte infiltration and which inflammatory cell population was responsible for the aneurysm progression. Immunohistochemical staining showed abundant leukocyte infiltration within the aortic media of the Smad4 mutants at 6 weeks old ( Figure 5A ). The infiltrating cells consisted predominantly of macrophages (CD68 + ). T lymphocytes (CD3 + ) and mast cells (CD117 + ) were also easily detected, but did not serve as the major subpopulations ( Figure 5A ). We performed a microarray assay using the aortic tissues of 6-week-old mice and showed a dramatic 12-fold and 5-fold upregulation of CTSS and MMP12, respectively, in the mutant samples when compared with the controls (Online Table I ). Consistently, we detected increases of the 2 proteases located predominantly Figure XVII) , suggesting that the infiltrated leukocytes were the major derivation of these proteases along with the aortic aneurysm progressed.
To address the role of macrophage infiltration in the progression of aneurysms resulting from Smad4 deficiency, a circulating monocyte/macrophage depletion assay was performed in the α-SMA-Cre;Smad4 fl/fl mice using clodronate-containing liposomes. The efficacy of the systematic treatment was confirmed by a reduction in the splenic macrophages (Online Figure XVIII) . Notably, monocyte/macrophage depletion significantly improved the survival of α-SMA-Cre;Smad4 fl/fl mice, with >60% of the mice still alive 30 days after treatment when compared with ≈ 10% survival in the control group ( Figure 5B ). We found that macrophage accumulation in the mutant aortic wall was also remarkably decreased ( Figure 5C and 5D). Importantly, the disrupted cellular structure and the impaired matrix arrangement were largely abrogated by monocyte/macrophage depletion ( Figure 5E ). Consistently, we showed a reduction in CTSS and MMP12 expression and an increased expression of the genes involved in elastin biosynthesis in the mutant aortic tissues along with macrophage depletion ( Figure 5F ). These findings support the notion that macrophages are crucial mediators for the progression of aortic aneurysms resulting from Smad4 deficiency in SMCs, presumably through secreting the proteases to directly damage elastic fibers. Supportively, both CTSS and MMP12 have been documented to be functionally correlated with the progression of inflammation-induced aortic aneurysm.
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Aberrant Chemokines Expression and Increased Macrophage Chemotaxis in Smad4-Deficient SMCs
We next explored whether TGF-β signaling disruption specifically in SMCs could directly trigger macrophage recruitment. First, we screened for the chemotactic factors involved in the aneurysm progression in the microarray data. The gene expression profile revealed an upregulation of numerous chemokines, including chemokine (C-C motif) ligand (CCL) and chemokine (C-X-C motif) ligand (CXCL) family members (Online Table II ). Consistently, the chemokine (C-C motif) receptor (CCR) and chemokine (C-X-C motif) receptor (CXCR) receptors and the monocyte/macrophage markers were profoundly upregulated, indicative of the intense leukocyte infiltration within the mutant aortic wall (Online Table II ). To find out the initial immune events and largely exclude the influence of inflammation in the adventitia, we analyzed the aortic tissues derived from 3-week-old mice with adventitia removed by micromanipulation and also detected a series of upregulated chemokines in the Smad4 mutants ( Figure 6A ). Among them, we focused on 2 chemokines, CCL2 and CXCL12, which have been previously reported to have monocyte chemotactic activity and play a role in vascular inflammation. 23 We verified the upregulation of the 2 chemokines in the Smad4-deficient SMCs ( Figure 6B ). In addition, Smad4 knockdown led to an evidently increased expression of CCL2 and CXCL12 ( Figure  6C ), indicative of a cell-autonomous regulation. Consistently, we found that TGF-β1 treatment inhibited CXCL12 expression in SMCs ( Figure 6D ). Whereas JNK activity modulated the expression of CCL2 in the Smad4-deficient SMCs (Figure Figure 6F ). The excessive production of CCL2 and CXCL12 in the Smad4-deficient SMCs was further identified in an ELISA assay ( Figure 6G ). Functionally, transwell migration assays demonstrated a significant stimulating role for the Smad4-deficient SMCs on macrophage chemotaxis ( Figure  6H ), in accordance with the excessive chemokines secretion from the Smad4-disrupted SMCs.
Blocking Selective Chemokine Signaling Partially Attenuates the Progression of Aortic Aneurysms Resulting From Smad4 Deficiency in SMCs
CCL2 signals via the CCR2 receptor expressed mainly on the inflammatory cells, and CXCL12 regulates leukocyte trafficking by binding to the CXCR4 receptor. 23 We proposed that the increased macrophage chemotactic activity of the Smad4-deficient SMCs was partially mediated by the activation of CCL2/CCR2 and CXCL12/CXCR4 signaling. To test this hypothesis, we used RS 504393 and AMD3100, selective blockades of CCR2 and CXCR4, respectively, in the transwell migration assays. The CCR2 antagonist RS 504393 completely abrogated the stimulating role of the Smad4-deficient SMCs on macrophage chemotaxis, but had no effect on the control group ( Figure 7A) . Similarly, the CXCR4 antagonist AMD3100 attenuated the induction effects of the Smad4-deficient SMCs ( Figure 7B ). Therefore, we concluded that Smad4 disruption specifically in SMCs directly triggered macrophage recruitment via the excessive production of the chemokines.
We used selective blockades in the α-SMA-Cre;Smad4
fl/fl mice to assess whether the activated chemotaxis contributed to the progression of aortic aneurysms resulting from Smad4 deficiency in SMCs. Treatment with the CCR2 antagonist RS 504393 significantly reduced the mortality of the mutant mice when compared with the dimethyl sulfoxide control group ( Figure 7C) . Histological analysis and quantitative evaluation showed that RS 504393 administration led to the markedly decreased macrophage infiltration in the aortic wall of the mutants ( Figure 7D ; Online Figure XX) . Notably, the destruction of elastic fiber was largely blocked ( Figure 7E ). We also tried the blockade of CXCL12/CXCR4. Systematic application of AMD3100 also showed an increase in survival. The protective effects were not as robust as RS 504393 but still exhibited statistical significance (Online Figure XXI) . Although the aortic dilation was not blocked, the dissection along with the macrophage infiltration and elastic fiber fragmentation were all partially attenuated (Online Figure XXI) .
Discussion
The present study provided in vivo functional evidence for a previously unknown requirement of endogenous Smad4 signaling confined to the SMCs to maintain the homeostasis of the aortic wall. As the unique central mediator of canonical TGF-β signaling, Smad4 might play essential but complicated roles within distinct cellular components of the vessel wall. Although evidence from clinical and mouse models suggests a correlation between Smad4 deficiency and aortic aneurysms, the cell type responsible for the pathogenesis is by far unknown.
9-12 SMAD4 mutations have been proven as one of the genetic causes of hereditary hemorrhagic telangiectasia, a vascular malformation syndrome. [24] [25] [26] Furthermore, deletion of Smad4 in endothelial cells largely recapitulates the vascular performance in patients with hereditary hemorrhagic telangiectasia, emphasizing the critical role of endothelial Smad4 in microvascular behaviors. 27, 28 In this study, deletion of Smad4 specifically in SMCs led to the inevitable occurrence of an aortic aneurysm. To our knowledge, this is the first genetic mouse model that establishes a causal relationship between Smad4 single gene deficiency and aortic aneurysms. Importantly, the pathologic features of the SMC-specific Smad4 knockout mice largely mimicked the vascular phenotypes in patients with LDS, including widespread aneurysm, early dissection, and medial degeneration with elevated pSmad2 and CTGF expression. [5] [6] [7] [8] These findings further highlight the disturbance of TGF-β signaling in SMCs implicated in the vascular pathogenesis of LDS.
Overall, our findings suggest the Smad4-dependent canonical TGF-β signaling in aortic SMCs as a key barrier to constrain the initiation of aortic aneurysms. Supportively, conditional deletion of Tgfbr2 in postnatal SMCs leads to the formation of aortic aneurysms, indicating the requirement of basal TGF-β signaling in SMCs in postnatal aortic wall homeostasis. 29 Several mechanisms underlying the disruption of TGF-β signaling in SMCs have been proposed to be involved in the pathogenesis of aortic aneurysms, including disturbed proliferation, impaired contractile apparatus, and defective elastogenesis. [29] [30] [31] [32] Here, we demonstrated a consistent increase of the proteases CTSS and MMP12 in the aortic aneurysms caused by Smad4 or Tgfbr2 deletion in SMCs. Importantly, the derivation of these excessive proteases was predominantly from medial SMCs at relatively early stages without extensive infiltration of inflammatory cells. Considering the destructive effects of CTSS and MMP12 in the aortic wall, 21, 22, [33] [34] [35] [36] we propose that Smad4-dependent TGF-β signaling in SMCs protects against aortic aneurysm formation at least partially via restricting the expression of the proteases essential for elastin degradation. Of note, neither CTSS nor MMP12 has ever been reported to be involved in thoracic aortic aneurysms. The modulating effects of TGF-β on the expression of MMP12 are largely cell type dependent. TGF-β1 induces MMP12 expression in epithelial tumor cells, 37 inhibits cytokine-mediated induction of MMP12 mRNA, protein, and enzymatic activity in macrophages, 38 and has no significant effect on MMP12 induction in airway SMCs. 39 We revealed a previously unknown downregulation of MMP12 by TGF-β in the aortic SMCs, which is largely abrogated in the absence of Smad4. In accordance with our findings, previous report shows no effects of TGF-β1 on the regulation of CTSS in SMCs. 40 The molecular mechanisms through which TGF-β signaling deficiency in SMCs causes the CTSS elevation under physiological conditions needs further investigations. We hope this work will shed new light on the underlying mechanisms on the involvement of TGF-β in the initiation of aortic aneurysms.
The present data also propose the existence of an increased noncanonical JNK signaling accompanying the development of aortic aneurysms resulting from Smad4 deficiency in SMCs. Similarly, introduction of Smad4 haploinsufficiency into the Marfan syndrome mouse model leads to an activation of JNK1. 12 Similar to our findings, accumulating evidence suggests several pathways besides Smads, such as JNK, extracellular signal-regulated kinase, p38 mitogen-activated protein kinase, and Stat3, in mediating the TGF-β-induced upregulation of CTGF. [41] [42] [43] Nevertheless, our data showed that the activation of JNK and the consequently increased CTGF in the Smad4 mutants was dispensable for the initiation of aortic aneurysms by TGF-β signaling deficiency in SMCs. We propose that the simultaneously increased noncanonical JNK activation in the Smad4 mutants might contribute to the severity and the inflammation-mediated progression of the aortic aneurysms at least partially by modulating the expression of MMP12 and CCL2 in SMCs. The underlying mechanisms for the activation of certain noncanonical pathways in the absence of Smad4 in SMCs needs further investigations.
Our data are first to uncover a stimulating role of the SMCs with disrupted TGF-β signaling in triggering aortic wall inflammation, which ultimately contributes to the progression of aortic aneurysms. We showed that Smad4 deficiency in SMCs directly recruited the macrophages via the excessive production of the chemokines. Considering the facilitating role of CTSS in monocyte/macrophage migration to the vascular wall, 36, 44 we could not exclude the possibility that the upregulation of CTSS resulting from Smad4 deficiency in SMCs might cooperatively contribute to the macrophage recruitment. By virtue, in the aortic tissues of the aneurysm mouse models established by Tgfbr2 disruption in postnatal SMCs, the macrophage markers, CD68 and CD11b, both manifest a 2-fold increase when compared with the control mice, suggesting the macrophages as the major infiltrating leukocytes although the mechanism and the influence of such infiltration have not been evaluated. 29 Literatures have demonstrated a critical role of macrophage infiltration in the progression of aortic aneurysms resulting from angiotensin II-induced vascular inflammation. 22, 45, 46 In such circumstances, aortic adventitia is the main location for the excessive production of the inflammatory factors with macrophage chemotactic activity. 46 Previous reports have shown the essential roles of Smad3 in suppressing vascular inflammation and protecting against aortic aneurysms. 45, 47, 48 It has been suggested that in the pathogenesis of the aortic aneurysms resulting from Smad3 deficiency, the defect is confined to the inflammatory cells. 48 However, the exact function of Smad3 in the medial SMCs is poorly investigated because of the complete knockout strategies in those studies. Here by taking advantages of the conditional knockout strategy, we emphasized that medial SMCs, besides adventitia fibroblasts or myofibroblasts, could instigate vascular inflammation during the development of aortic aneurysms. It is unlikely that adventitial myofibroblasts are major contributors for the recruitment of inflammatory cell infiltration, as the α-SMA-Cre-mediated ablation did not occur in the myofibroblasts, and no apparent increases of myofibroblasts were detected in the 6-week-old Smad4 mutants, when the aneurysm was more aggressive than in younger mice (Online Figure XXII) . Of note, although harbored some inflammatory characteristics, the Smad4 mutants showed unaltered MMP2, MMP9, and oxidative stress, known as common mediators in the inflammation-induced aortic aneurysm models. These findings further suggest that distinct features might correlate with the different cell origins to trigger the inflammation in the context of an aortic aneurysm.
We further revealed the selective chemokine axis as the potential executors responsible for the recruitment of macrophages and the consequent progression of aortic aneurysms resulting from Smad4 deficiency in SMCs. The role of the CCL2/CCR2 and CXCL12/CXCR4 chemokine pathways has been investigated in the inflammation-induced aortic aneurysms. 46 ,49-52 Pharmacologic blockade of the CCL2/CCR2 axis has shown variable outcomes. Circulating inhibition of CCL2 leads to the increased severity of abdominal aortic aneurysms, whereas siRNA-induced CCR2 inhibition in leukocytes results in a significantly reduced aneurysm formation in aging apolipoprotein E-deficient mice with pre-existing atherosclerotic lesions. 51 In line with our findings, the CXCR4 antagonist AMD3100 suppresses the formation and progression of abdominal aortic aneurysms in CaCl 2 -induced mouse models. 49 Nowadays, the management strategies for the medical and surgical treatment of inherited aortic aneurysms are becoming increasingly gene tailored. 1 Even though LDS is caused by genetic mutations, we proposed that the prevailing leukocyte infiltration and dissection endows the syndrome with several similar features of vascular inflammatory diseases. Blockade of certain inflammatory axes may be an attractive approach to limit the progression of the aneurysms. ROSA-EYFP reporter mice were purchased from the Jackson Laboratory. All animals were maintained at C57BL/6 genetic background, kept under specific pathogen-free conditions, approved by the Animal Care and Use Committee, and handled in accordance with institutional guidelines for laboratory animals. All experiments were performed with both male and female mice. Control mice were sex-matched littermates.
Supplemental Methods
Echocardiography
Mice were anesthetized with tribromoethanol and analyzed for anatomy and function on a Vivid 7 Dimension cardiovascular ultrasound system with a 12-MHz microprobe (GE Healthcare). Echocardio graphic measurements were taken on M-mode in triplicate from more than 5 separate mice per group.
Animal Treatment
Circulating monocytes were depleted using liposomes containing clodronate as previously described. 4 , 5 3-week-old mice were injected with 150 μl clodronate-or PBS-liposomes via orbital venous every 7 days and for totally 5 times. The efficiency of macrophage depletion was assessed by CD68 staining in the spleen determined by immunohistochemistry. For pharmacologic treatments, the CCR2 inhibitor RS 504393 (Sigma, SML0711) was reconstituted in 10% DMSO at a concentration of 1 mg/ml and administered via intraperitoneal injection every day at a dose of 10 mg/kg body weight. The same volume of 10% DMSO was used with the controls. The CXCR4 inhibitor ADM3100 (Sigma, A5602) was reconstituted in PBS at a concentration of 0.5 mg/ml and administered via intraperitoneal injection every 2 days at a dose of 5 mg/kg body weight. All pharmacologic treatments were initiated at 3-week-old and lasted till 2 months of age.
Histology
Hematoxylin and eosin (H&E), immunohistochemistry and immunofluorescence staining were performed on paraffin-embedded or frozen sections using standard procedures. Verhoeff-Van Gieson staining was performed as previously described. 6 For the 5-bromo-2'-deoxyuridine (BrdU, Sigma) incorporation assay, BrdU (10 μg/g body weight) was intraperitoneally injected into the mice 6 hours before dissection. Primary antibodies used for immunostaining were as follows 
In Situ Zymography
In situ zymography was performed as previously described. 8 The elastinolytic activity was assessed on 10 μM frozen aortic sections using an EnzChek Elastase Assay Kit (Molecular Probes, E12056). Samples were incubated at 37°C for 24 hours with a fluorogenic elastin substrate (DQ elastin, Invitrogen), and then examined with a fluorescent microscope.
Oxidase Stress Assay
Oxidase Stress was evaluated on the aortic tissue sections by an OxyIHC TM Oxidative Stress Detection Kit (Millipore, S7450) according to the manufacturer's instruction. Negative control reaction was performed on a wild type aortic section with the Derivatization Control Solution.
Cell Culture
Primary aortic smooth muscle cells (SMCs) were isolated from the thoracic aortas of 3-week-old mice or 4-week-old rats as previously described. 9, 10 The cells used in the experiments were from passage 3 to 8 with at least 95% purity. The rat aortic smooth muscle cell line A10 was purchased from the ATCC. For TGF-β1 (R&D, 240-B), TGF-β3 (R&D, 8420-B3) and JNK inhibitor SP600125 (Sigma, S5567) stimulation, cells were staved for 24 hours before treatment. Sequences for Smad4-siRNA and Smad2-siRNA were designed and obtained from GenePharma. For Smad4 and Smad2 knockdown, primary aortic SMCs or A10 cells were transfected with 20 nM specific siRNA or scrambled Oligo using jetprime transfection regents (PolyPlus-Transfection) according to the manufacturer's instructions. For overexpression, primary rat aortic SMCs were transfected with hSMAD4 or hSMAD2 expression plasmids or vector controls using Lipofectamine 2000 (Invitrogen) according to the manufacturer's recommendation. Cells were harvested 24-48 hours later for future use.
Chemotaxis Assay
Primary mouse peritoneal macrophages were obtained by lavage with PBS as previously described.
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Peritoneal washes were performed on 6-week-old wild-type female mice. Chemotaxis was assessed in 24-well plates using 6.5 mm transwell inserts with 5-μm pore polycarbonate membranes (Corning, 3421). Primary mouse SMCs or A10 cells were added to the lower chamber of the transwell at a density of 8 x 10 4 per well. Then, 2.5 x 10 4 primary mouse peritoneal macrophages were seeded in the upper chamber. Pharmacologic regents, with a final concentration of 10 μg/ml for RS 504393 and 5 μg/ml for AMD3100, were selectively added simultaneously. The inserts were incubated at 37°C for 24 hours. Non-migrated cells were removed from the top side of the inserts with a cotton swab. Cells remaining on the lower part of the inserts were fixed with methanol for 10 minutes and stained with Crystal violet. All experiments were performed in triplicate. Migratory cells were evaluated with optical microscopy. The results are presented as the relative number of cells compared to the wild type control group.
Western Blot
Proteins were collected from the aortic tissues or cultured SMCs using RIPA lysis buffer. In some cases, adventitia was carefully removed by micromanipulation. Gelatin Zymography MMP2 and MMP9 activity in the aortic tissue extracts was assessed with a gelatin zymography assay. 20 μg of total protein were resolved by nondenaturing electrophoresis through a 10% polyacrylamide gel containing 0.1% (w/v) gelatin. After electrophoresis, the gel was washed twice in 2.5% Triton-X 100 for 30 minutes and incubated with reaction buffer (50 mM Tris-HCl, 5 mM CaCl 2 , and 0.02% NaN3, pH 8.0) for 18 hours at 37°C. The gelatinolytic activity was detected as clear bands by Coomassie blue G-250 staining of the gel.
ELISA
For cytokine production measurements, cell supernatants of the primary aortic SMCs at passage 3 were assessed for the protein levels of CCL2 and CXCL12 using specific ELISA kits (Quantikine, R&D system) according to the manufacturer's instructions.
Morphometric and Expression Level Quantization
Images of CD68 immunohistochemistry were digitally captured and CD68-positive cells in the aortic wall were counted in 10 contiguous sections manually and blindly. Expression level by western blot analysis was quantified by Image J software.
Flow Cytometry
Aortas were minced into small pieces and digested by collagenase as described previously. 12 Three aortas with the same genotype were pooled as one sample. Single cells were resuspended in PBS containing 0.5% BSA and stained with PE-CD11b (eBioscience) for 30 minutes at 37°C. 7-aminoactinomycin D (7-AAD, eBioscience) was used to exclude dead cells. Stained cells were analyzed with FACSCalibur flow cytometer (BD Biosciences). Data were analyzed with FlowJo software (Tree Star). For apoptotic analysis, cultured SMCs were stained with FITC-Annexin V (eBioscience) and 7-AAD according to the manufacturer's instruction. Propidium iodide staining was performed to assess the cell cycle status using standard procedures.
RNA Isolation and Quantitative Real-time PCR
RNA was extracted from the aortic tissues or cultured SMCs by Trizol (Invitrogen). In some cases, adventitia was carefully removed by micromanipulation. Real-time PCR reactions were run with the 7500 Real-Time PCR System (Applied Biosystems). Relative expression levels were calculated using the ΔΔCt method, with normalization to the level of GAPDH in the same samples. Data are represented as fold changes as compared to the control groups. Sequences of specific primers were self-designed and are listed as follows. 
Statistical Analysis
Data were analyzed using the SPSS software (SPSS Inc.) or Prism 5 software (GraphPad). The data are presented as mean values ± standard deviation (SD). The Student t-test was used for comparisons between 2 groups. One-way ANOVA with the least significant difference or Tamhane's T2 post-hoc test was used for comparisons between more than 2 groups. Kaplan-Meier methods were used to compare survival curves. P < 0.05 was considered to be statistically significant.
Supplemental Tables
Online Table I immunostaining shows no effect of Smad4 knockdown or overexpression on the cell morphology of the primary rat aortic SMCs. Data are means ± SD. ***P < 0.001; **P < 0.01; *P < 0.05; NS, not significant. Scale bars: 20 μm (C) and 100 μm (E). 
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